1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 28 Hits
  • Search Condition : Filter (MeSH = Deoxycytidine / pharmacology)
Species Resource
Mice PD-1-KO-N12 (BALB/c)(RBRC00904) Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis.
DNA material pGEX-6P-3/GST-TAT-ODD/3-0-Casp3 (RDB14403) , pEF/HRE-Fluc (RDB14404). Hypoxia-inducible factor-targeting prodrug TOP3 combined with gemcitabine or TS-1 improves pancreatic cancer survival in an orthotopic model.
Human and Animal Cells SSP-25(RCB1293) , RBE(RCB1292) , TKKK(RCB1907) , HuCCT1(RCB1960) High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.
Human and Animal Cells TKKK(RCB1907) , TGBC24TKB(RCB1196) , HuCCT1(RCB1960) PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay.
Human and Animal Cells NOR-P1(RCB2139) Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells.
Human and Animal Cells TFK-1(RCB2537) Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
Human and Animal Cells HuCCT1(RCB1960) Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
Human and Animal Cells NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors.
Human and Animal Cells PC-9(RCB4455) Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells.
Human and Animal Cells PK-59(RCB1901) Fucosylation is a common glycosylation type in pancreatic cancer stem cell-like phenotypes.
Human and Animal Cells PK-45P(RCB2141) , PK-1(RCB1972) Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.
Human and Animal Cells TGBC1TKB(RCB1129) Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK.
Human and Animal Cells TKKK(RCB1907) Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth.
Human and Animal Cells Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis.
Human and Animal Cells Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.
Human and Animal Cells PK-45H(RCB1973) , PANC-1(RCB2095) , PK-59(RCB1901) , KP4-1(RCB1006) , PK-1(RCB1972) Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.
Human and Animal Cells Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro.
Human and Animal Cells Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells.
Human and Animal Cells Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells.
Human and Animal Cells The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer.